metformin vs glp-1 Synergistic effects of with liraglutide against endothelial dysfunction through receptor and PKA signalling pathway GLP-1 RA initiation versus metformin

The contraceptive guidance follows the molecule, not the brand name

(Survey conducted by Pendulum.) (*These statements have not been evaluated by the Food and Drug Administration

however, there have been postmarketing reports of ketoacidosis and/or glucosuria lasting greater than 6 days and some up to 2 weeks after discontinuation of SGLT2 inhibitors

Eli Lilly, the makers of Zepbound, gained FDA approval for its drug orforglipron, sold under the brand name Foundayo, on April 1, 2026, following Novo Nordisk, which received approval for the Wegovy pill in December 2025

A Morgan Stanley survey conducted earlier this year among GLP-1 drug users including those using the treatments for diabetes found that about two-thirds of respondents had their medication fully covered by insurance

What is the Wegovy vision loss lawsuit about